<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rsp</journal-id><journal-title-group><journal-title xml:lang="ru">Научно-практическая ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Rheumatology Science and Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-4484</issn><issn pub-type="epub">1995-4492</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/1995-4484-2000-789</article-id><article-id custom-type="elpub" pub-id-type="custom">rsp-926</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>РОЛЬ МОЛЕКУЛ АДГЕЗИИ В ПАТОГЕНЕЗЕ РЕВМАТОИДНОГО АРТРИТА</article-title><trans-title-group xml:lang="en"><trans-title>ROLE OF ADHESION MOLECULES IN THE PATHOGENESIS OF RHEUMATOID ARTHRITIS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Yarilin</surname><given-names>A. A.</given-names></name><name name-style="western" xml:lang="en"><surname>Yarilin</surname><given-names>A. A.</given-names></name></name-alternatives><email xlink:type="simple">-</email></contrib></contrib-group><pub-date pub-type="collection"><year>2000</year></pub-date><pub-date pub-type="epub"><day>15</day><month>02</month><year>2000</year></pub-date><volume>38</volume><issue>1</issue><issue-title>№1 (2000)</issue-title><fpage>61</fpage><lpage>68</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Yarilin A.A., 2000</copyright-statement><copyright-year>2000</copyright-year><copyright-holder xml:lang="ru">Yarilin A.A.</copyright-holder><copyright-holder xml:lang="en">Yarilin A.A.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://rsp.mediar-press.net/rsp/article/view/926">https://rsp.mediar-press.net/rsp/article/view/926</self-uri></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">&lt;div&gt;&lt;p&gt;Козлов И.Г., Горлина Н.К., Чередеев А.Н. Рецепторы контактного взаимодействия. Иммунология., 1995, 6, 14-25.&lt;/p&gt;&lt;p&gt;Насонов Е.Л. Противовоспалительная терапия ревматических болезней. М.: М- Сити., 1996, 345.&lt;/p&gt;&lt;p&gt;Albert-Wolf М, Meuer S.C., Wallich R. Dual function of recombinant human CD58: inhibition of T cell adhesion and activation via CD2 pathway. Int. Immunol., 1991, 3 , 1335-1347.&lt;/p&gt;&lt;p&gt;Aoki S., Imai K., Yachi A. Soluble intercellular adhesion molecule-1 (ICAM-1) antigen in patients with rheumatoid arthritis. Scand. J. Immunol., 1993 , 38, 485-490.&lt;/p&gt;&lt;p&gt;Bierer B.E., Hahn W.C. T cell adhesion, avidity regulation and signaling: a molecular analysis of CD2. Semin. Immunol., 1993, 5, 249-261.&lt;/p&gt;&lt;p&gt;Blann A.D., Herrick A., Jayson M.I.V. Altered levels of soluble adhesion molecules in rheumatoid arthritis, vasculitis and systemic sclerosis. British J. Rheumatol., 1995,34,814-819.&lt;/p&gt;&lt;p&gt;Buck C.A. Immunoglobulin superfamily: structure, function, and relationship to other receptor molecules. Semin. Cell. Biol, 1992, 3, 179188.&lt;/p&gt;&lt;p&gt;Butcher E.C., Picker L. J. Lymphocyte homing and homeostasis. Science, 1996, 272, 60-66.&lt;/p&gt;&lt;p&gt;Carson C.W., Beall L. D., Hunder G. G., et al. Soluble E-selectin is increased in inflammatory synovial fluid. J. Rheumatol., 1994, 21, 605-611.&lt;/p&gt;&lt;p&gt;Chavin K.D., Qin L., Lin J. et al. Combinated anti-CD2 and anti-CD3 receptor monoclonal antibodies induce donor-specific tolerance in a cardiac transplant model. J. Immunol., 1993, 151, 7249-7259.&lt;/p&gt;&lt;p&gt;Clark E.A., Ledbetter JA. How В and T cells talk to each other. Nature., 1994, 367, 425-428.&lt;/p&gt;&lt;p&gt;Clark E.A., Brugge J.S. Integrins and signal transduction pathways. The road taken. /Science, 1995. 268, 233-239.&lt;/p&gt;&lt;p&gt;Cush J.J., Lipsky P.E. Phenotypic analysis of synovial tissue and peripheral blood lymphocytes isolated from patients with rheumatoid arthritis. Arthritis Rheum., 1988, 31, 1230-1238.&lt;/p&gt;&lt;p&gt;Cush J.J., Pietschmann P., Oppenheimer-Marks N., et al. The intrinsic migratory capacity of memory T cells contributes to their accumulation in rheumatoid synovium. Arthritis Rheum., 1992, 35, 1434-1444.&lt;/p&gt;&lt;p&gt;Edwards J.C.W., Wilkinson L.S., Speight P., Isenberg D.A. Vascular cell adhesion molecule 1 and a4 and bl integrins in lymphocyte aggregates in Sjogren’s syndrome and rheumatoid arthritis. Ann. Rheum. Dis., 1993, 52, 806-811.&lt;/p&gt;&lt;p&gt;Finck B.K., Linsley P.S., Wofsy D. Treatment of murine lupus with CTLA41g. Science, 1994, 265, 1225-1227.&lt;/p&gt;&lt;p&gt;FitzGerald O. Advances in understanding and therapeutic targets in inflammatory arthritis. Ir. Med. Sci., 1995, 164,4-11.&lt;/p&gt;&lt;p&gt;Fox D.A The role of T cells in the immuno- pathogenesis of rheumatoid arthritis. Arthritis Rheum., 1997, 40, 598-609.&lt;/p&gt;&lt;p&gt;Gearing A.J., Newman W. Circulating adhesion molecules in disease. Immunol. Today, 1992, 14, 506-512.&lt;/p&gt;&lt;p&gt;Girard J.P., Springer T.A. High endothelial venules (HEVs): specialized endothelium for lymphocyte migration. Immunol. Today, 1995, 16, 449-457.&lt;/p&gt;&lt;p&gt;Hale L.P., Mart M.E., McCollum D.E. et al. Immunohistologic analysis of the distribution of cell adhesion molecules within the inflammatory synovial microenvironment.Arthritis Rheum., 1989, 32, 22-30.&lt;/p&gt;&lt;p&gt;Haynes B.F., Hale L.P., Patton K.L., et al. Measurement of an indicator of inflammatory disease activity: up-regulation of the receptor for hyaluronate (CD44) in rheumatoid arthritis. Arthritis Rheum., 1991, 34, 1434-1443.&lt;/p&gt;&lt;p&gt;Hebbar М., Lassale P., Janin A., et al. E-selectin expression in salivary endothelial cells and sera from patients with systemic sclerosis. Arthritis Rheum., 1995, 38, 406-412.&lt;/p&gt;&lt;p&gt;Iguchi Т., Ziff M. Electron microscopic study of rheumatoid synovial vasculature: intimate relationship between tall endothelium and lymphoid aggregates. J. Clin. Invest., 1986,77,355361.&lt;/p&gt;&lt;p&gt;Ishikawa H., Hirata S., Nishibayashi Y., et al. The role of adhesion molecules in synovial pan- nus formation in rheumatoid arthritis. Clin. Orthop, 1994, 300, 297-303.&lt;/p&gt;&lt;p&gt;Ishikawa H, Nishibayashi Y, Kita K, et al. Adhesion molecules in the lymphoid cell distribution in rheumatoid synovial membrane. Bull. Hosp. Joint Dis., 1993, 53, 23-28.&lt;/p&gt;&lt;p&gt;Johnson B.A., Haines G.K., Harlow L.A., Koch A. E. Adhesion molecule expression in human synovial tissue. Arthritis Rheum., 1993, 36, 137-146.&lt;/p&gt;&lt;p&gt;Kansas G.S. Selectins and their ligands: current concepts and controversies. Blood., 1996, 88, 3259-3287.&lt;/p&gt;&lt;p&gt;Kavanaugh A.F., Davis L.S., Nichols L.A., et al. Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule-1. Arthritis Rheum., 1994, 37, 992-999.&lt;/p&gt;&lt;p&gt;Koch A.E., Burrows J.C., Haines G.K. et al. Immunolocalization of endothelial and leukocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissues. Lab. Invest., 1991, 64, 313-320.&lt;/p&gt;&lt;p&gt;Koch A.E., Shah M.R., Harlow L.A., et al. Soluble intercellular adhesion molecule-1 in arthritis. Clin. Immunol. Immunopathol.,1994, 71, 208-215.&lt;/p&gt;&lt;p&gt;Koopman G., Keehnen R.M., Lindhout E., et al. Adhesion through the LFA-1 (CDlla/ CDI8)-ICAM-1 (CD54) and the VLA-4 (CD49d)-VCAM-1 (CD 106) pathways prevents apoptosis of germinal center В cells. J. Immunol., 1994, 152, 3760-3767.&lt;/p&gt;&lt;p&gt;Krigsmann J., Keyszer G.M., Geiler T. et al. Expression of E-selectin messenger RNA and protein in rheumatoid arthritis. Arthritis Rheum., 1995, 38, 750-754.&lt;/p&gt;&lt;p&gt;Lamphear J.G., Stevens K.R., Rich R.R. ICAM-1 and LFA-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule. J. Immunol., 1998, 160, 615-623.&lt;/p&gt;&lt;p&gt;Ley K., Tedder T.F. Leukocyte interactions with vascular endotelium. New insights into selectin- mediated attachment and rolling. J. Immunol., 1995, 155, 525-528.&lt;/p&gt;&lt;p&gt;Liao H.X., Haynes B.F. Role of adhesion molecules in the pathogenesis of rheumatoid arthritis. Rheum. Dis. Clin. North Am., 1995, 21,715740.&lt;/p&gt;&lt;p&gt;Littler A.J., Buckley C.D., Wordsworth P. eet al. A distinct profile of six soluble adhesion molecules (ICAM-1, ICAM-3, VCAM-1, E-selectin, L-selectin and P-selectin) in rheumatoid arthritis. /British J. Rheumatol., 1997, 36, 164-169.&lt;/p&gt;&lt;p&gt;Masumoto A., Hemler M.E. Multiple activation states of VLA-4: mechanistic differences&lt;/p&gt;&lt;/div&gt;&lt;br /&gt;</mixed-citation><mixed-citation xml:lang="en">&lt;div&gt;&lt;p&gt;Козлов И.Г., Горлина Н.К., Чередеев А.Н. Рецепторы контактного взаимодействия. Иммунология., 1995, 6, 14-25.&lt;/p&gt;&lt;p&gt;Насонов Е.Л. Противовоспалительная терапия ревматических болезней. М.: М- Сити., 1996, 345.&lt;/p&gt;&lt;p&gt;Albert-Wolf М, Meuer S.C., Wallich R. Dual function of recombinant human CD58: inhibition of T cell adhesion and activation via CD2 pathway. Int. Immunol., 1991, 3 , 1335-1347.&lt;/p&gt;&lt;p&gt;Aoki S., Imai K., Yachi A. Soluble intercellular adhesion molecule-1 (ICAM-1) antigen in patients with rheumatoid arthritis. Scand. J. Immunol., 1993 , 38, 485-490.&lt;/p&gt;&lt;p&gt;Bierer B.E., Hahn W.C. T cell adhesion, avidity regulation and signaling: a molecular analysis of CD2. Semin. Immunol., 1993, 5, 249-261.&lt;/p&gt;&lt;p&gt;Blann A.D., Herrick A., Jayson M.I.V. Altered levels of soluble adhesion molecules in rheumatoid arthritis, vasculitis and systemic sclerosis. British J. Rheumatol., 1995,34,814-819.&lt;/p&gt;&lt;p&gt;Buck C.A. Immunoglobulin superfamily: structure, function, and relationship to other receptor molecules. Semin. Cell. Biol, 1992, 3, 179188.&lt;/p&gt;&lt;p&gt;Butcher E.C., Picker L. J. Lymphocyte homing and homeostasis. Science, 1996, 272, 60-66.&lt;/p&gt;&lt;p&gt;Carson C.W., Beall L. D., Hunder G. G., et al. Soluble E-selectin is increased in inflammatory synovial fluid. J. Rheumatol., 1994, 21, 605-611.&lt;/p&gt;&lt;p&gt;Chavin K.D., Qin L., Lin J. et al. Combinated anti-CD2 and anti-CD3 receptor monoclonal antibodies induce donor-specific tolerance in a cardiac transplant model. J. Immunol., 1993, 151, 7249-7259.&lt;/p&gt;&lt;p&gt;Clark E.A., Ledbetter JA. How В and T cells talk to each other. Nature., 1994, 367, 425-428.&lt;/p&gt;&lt;p&gt;Clark E.A., Brugge J.S. Integrins and signal transduction pathways. The road taken. /Science, 1995. 268, 233-239.&lt;/p&gt;&lt;p&gt;Cush J.J., Lipsky P.E. Phenotypic analysis of synovial tissue and peripheral blood lymphocytes isolated from patients with rheumatoid arthritis. Arthritis Rheum., 1988, 31, 1230-1238.&lt;/p&gt;&lt;p&gt;Cush J.J., Pietschmann P., Oppenheimer-Marks N., et al. The intrinsic migratory capacity of memory T cells contributes to their accumulation in rheumatoid synovium. Arthritis Rheum., 1992, 35, 1434-1444.&lt;/p&gt;&lt;p&gt;Edwards J.C.W., Wilkinson L.S., Speight P., Isenberg D.A. Vascular cell adhesion molecule 1 and a4 and bl integrins in lymphocyte aggregates in Sjogren’s syndrome and rheumatoid arthritis. Ann. Rheum. Dis., 1993, 52, 806-811.&lt;/p&gt;&lt;p&gt;Finck B.K., Linsley P.S., Wofsy D. Treatment of murine lupus with CTLA41g. Science, 1994, 265, 1225-1227.&lt;/p&gt;&lt;p&gt;FitzGerald O. Advances in understanding and therapeutic targets in inflammatory arthritis. Ir. Med. Sci., 1995, 164,4-11.&lt;/p&gt;&lt;p&gt;Fox D.A The role of T cells in the immuno- pathogenesis of rheumatoid arthritis. Arthritis Rheum., 1997, 40, 598-609.&lt;/p&gt;&lt;p&gt;Gearing A.J., Newman W. Circulating adhesion molecules in disease. Immunol. Today, 1992, 14, 506-512.&lt;/p&gt;&lt;p&gt;Girard J.P., Springer T.A. High endothelial venules (HEVs): specialized endothelium for lymphocyte migration. Immunol. Today, 1995, 16, 449-457.&lt;/p&gt;&lt;p&gt;Hale L.P., Mart M.E., McCollum D.E. et al. Immunohistologic analysis of the distribution of cell adhesion molecules within the inflammatory synovial microenvironment.Arthritis Rheum., 1989, 32, 22-30.&lt;/p&gt;&lt;p&gt;Haynes B.F., Hale L.P., Patton K.L., et al. Measurement of an indicator of inflammatory disease activity: up-regulation of the receptor for hyaluronate (CD44) in rheumatoid arthritis. Arthritis Rheum., 1991, 34, 1434-1443.&lt;/p&gt;&lt;p&gt;Hebbar М., Lassale P., Janin A., et al. E-selectin expression in salivary endothelial cells and sera from patients with systemic sclerosis. Arthritis Rheum., 1995, 38, 406-412.&lt;/p&gt;&lt;p&gt;Iguchi Т., Ziff M. Electron microscopic study of rheumatoid synovial vasculature: intimate relationship between tall endothelium and lymphoid aggregates. J. Clin. Invest., 1986,77,355361.&lt;/p&gt;&lt;p&gt;Ishikawa H., Hirata S., Nishibayashi Y., et al. The role of adhesion molecules in synovial pan- nus formation in rheumatoid arthritis. Clin. Orthop, 1994, 300, 297-303.&lt;/p&gt;&lt;p&gt;Ishikawa H, Nishibayashi Y, Kita K, et al. Adhesion molecules in the lymphoid cell distribution in rheumatoid synovial membrane. Bull. Hosp. Joint Dis., 1993, 53, 23-28.&lt;/p&gt;&lt;p&gt;Johnson B.A., Haines G.K., Harlow L.A., Koch A. E. Adhesion molecule expression in human synovial tissue. Arthritis Rheum., 1993, 36, 137-146.&lt;/p&gt;&lt;p&gt;Kansas G.S. Selectins and their ligands: current concepts and controversies. Blood., 1996, 88, 3259-3287.&lt;/p&gt;&lt;p&gt;Kavanaugh A.F., Davis L.S., Nichols L.A., et al. Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule-1. Arthritis Rheum., 1994, 37, 992-999.&lt;/p&gt;&lt;p&gt;Koch A.E., Burrows J.C., Haines G.K. et al. Immunolocalization of endothelial and leukocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissues. Lab. Invest., 1991, 64, 313-320.&lt;/p&gt;&lt;p&gt;Koch A.E., Shah M.R., Harlow L.A., et al. Soluble intercellular adhesion molecule-1 in arthritis. Clin. Immunol. Immunopathol.,1994, 71, 208-215.&lt;/p&gt;&lt;p&gt;Koopman G., Keehnen R.M., Lindhout E., et al. Adhesion through the LFA-1 (CDlla/ CDI8)-ICAM-1 (CD54) and the VLA-4 (CD49d)-VCAM-1 (CD 106) pathways prevents apoptosis of germinal center В cells. J. Immunol., 1994, 152, 3760-3767.&lt;/p&gt;&lt;p&gt;Krigsmann J., Keyszer G.M., Geiler T. et al. Expression of E-selectin messenger RNA and protein in rheumatoid arthritis. Arthritis Rheum., 1995, 38, 750-754.&lt;/p&gt;&lt;p&gt;Lamphear J.G., Stevens K.R., Rich R.R. ICAM-1 and LFA-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule. J. Immunol., 1998, 160, 615-623.&lt;/p&gt;&lt;p&gt;Ley K., Tedder T.F. Leukocyte interactions with vascular endotelium. New insights into selectin- mediated attachment and rolling. J. Immunol., 1995, 155, 525-528.&lt;/p&gt;&lt;p&gt;Liao H.X., Haynes B.F. Role of adhesion molecules in the pathogenesis of rheumatoid arthritis. Rheum. Dis. Clin. North Am., 1995, 21,715740.&lt;/p&gt;&lt;p&gt;Littler A.J., Buckley C.D., Wordsworth P. eet al. A distinct profile of six soluble adhesion molecules (ICAM-1, ICAM-3, VCAM-1, E-selectin, L-selectin and P-selectin) in rheumatoid arthritis. /British J. Rheumatol., 1997, 36, 164-169.&lt;/p&gt;&lt;p&gt;Masumoto A., Hemler M.E. Multiple activation states of VLA-4: mechanistic differences&lt;/p&gt;&lt;/div&gt;&lt;br /&gt;</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
